Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06524037

Relationship Between Metabolic Profiles and Chronic Diseases and Neoplasms

Metabolic disorders are involved in the occurrence and development of a variety of chronic diseases and tumors. There are many common risk factors between chronic diseases and tumors. However, the mechanisms of chronic diseases and tumors caused by metabolic disorders are not completely clear. By observing the relationship between metabolic indexes and chronic diseases and tumors, the investigators intend to explore the possible mechanisms of metabolic status participating in the occurrence and development of chronic diseases and tumors.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

The First Branch of the Affiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, 400010, China

Location status: Recruiting

Location contact

Qin Duan, doctor

CONTACT

[email protected]

+8618623349865

About this study

Metabolic disorders are involved in the occurrence and development of a variety of chronic diseases and tumors, for example, metabolic diseases (hypertension, diabetes, dyslipidemia, obesity, etc.) can mediate the progression of chronic diseases such as heart failure and ischemic encephalopathy. Obesity can increase the risks of endometrial cancer, esophageal cancer, stomach cancer, etc. There are many common risk factors between chronic diseases and tumors, such as age, sex, smoking, genetics, obesity, unhealthy diet and lack of exercise. However, the mechanisms of chronic diseases and tumors caused by metabolic disorders are not completely clear. By observing the relationship between metabolic indexes and chronic diseases and tumors, the investigators intend to explore the possible mechanisms of metabolic status participating in the occurrence and development of chronic diseases and tumors.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adult aged ≥18 years old
  • Completed health screening

Exclusion criteria

  • aged <18 years old
  • pregnancy

Treatment and study plan

Primary outcomes

  1. metabolic disorder

    Time frame: through study completion, an average of 1 year

    The degree of metabolic disorder liking the levels of glycolipids

  2. Chronic disease

    Time frame: through study completion, an average of 1 year

    The occurrence of chronic disease

  3. Tumor

    Time frame: through study completion, an average of 1 year

    The occurrence of tumor

Study contacts

Contact information is provided by the study sponsor or research team.

Qin Duan, doctor

CONTACT

[email protected]

+8618623349865

Sponsors and collaborators

Lead sponsor

First Affiliated Hospital of Chongqing Medical University

Other

Registry information

Important dates

Study start
2022
Primary completion
2032
Study completion
2032
First posted
Jul 29, 2024
Registry last updated
Jul 29, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.